Smart for Life (SMFL) Competitors $0.02 +0.02 (+305.88%) As of 07/18/2025 03:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. HEPA, BPTSY, VRPX, VIRX, NCNA, BON, CAPS, MYMD, VINC, and UPCShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Viracta Therapeutics (VIRX), NuCana (NCNA), Bon Natural Life (BON), Capstone Therapeutics (CAPS), MyMD Pharmaceuticals (MYMD), Vincerx Pharma (VINC), and Universe Pharmaceuticals (UPC). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Its Competitors Hepion Pharmaceuticals Biophytis Virpax Pharmaceuticals Viracta Therapeutics NuCana Bon Natural Life Capstone Therapeutics MyMD Pharmaceuticals Vincerx Pharma Universe Pharmaceuticals Smart for Life (NASDAQ:SMFL) and Hepion Pharmaceuticals (NASDAQ:HEPA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends. Do insiders and institutionals have more ownership in SMFL or HEPA? 28.4% of Smart for Life shares are owned by institutional investors. Comparatively, 17.2% of Hepion Pharmaceuticals shares are owned by institutional investors. 31.7% of Smart for Life shares are owned by insiders. Comparatively, 0.1% of Hepion Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has better valuation & earnings, SMFL or HEPA? Smart for Life has higher revenue and earnings than Hepion Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.01-$22.68MN/AN/AHepion PharmaceuticalsN/AN/A-$48.93M-$219.000.00 Is SMFL or HEPA more profitable? Smart for Life's return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Hepion Pharmaceuticals N/A -812.56%-207.31% Which has more volatility & risk, SMFL or HEPA? Smart for Life has a beta of 17.24, indicating that its stock price is 1,624% more volatile than the S&P 500. Comparatively, Hepion Pharmaceuticals has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Does the media refer more to SMFL or HEPA? In the previous week, Smart for Life's average media sentiment score of 0.00 equaled Hepion Pharmaceuticals'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Hepion Pharmaceuticals Neutral SummarySmart for Life beats Hepion Pharmaceuticals on 7 of the 7 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$147K$3.44B$5.54B$9.40BDividend YieldN/AN/A3.75%4.03%P/E RatioN/A7.6228.0119.79Price / Sales0.0126.38432.5697.34Price / CashN/A5.6236.1658.27Price / Book0.001.108.125.65Net Income-$22.68M$17.44M$3.25B$257.91M7 Day PerformanceN/A-12.86%1.64%3.35%1 Month PerformanceN/A-6.41%7.27%11.09%1 Year PerformanceN/A-37.62%32.88%18.99% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.02+305.9%N/A-99.0%$147K$11.11M0.00110HEPAHepion Pharmaceuticals0.1377 of 5 stars$0.05-6.4%N/A-99.9%$528KN/A-0.0120Gap UpBPTSYBiophytisN/A$1.33-8.3%N/A-71.3%$467KN/A0.0030Gap DownVRPXVirpax PharmaceuticalsN/A$0.36-2.5%$75.00+20,675.6%-98.8%$448KN/A0.007VIRXViracta Therapeutics2.0262 of 5 stars$0.01-5.0%$1.75+18,129.2%N/A$382KN/A-0.0120High Trading VolumeNCNANuCana3.0679 of 5 stars$0.05+9.4%$25.00+49,700.8%-98.4%$280KN/A-0.0130Stock SplitGap UpHigh Trading VolumeBONBon Natural Life0.6073 of 5 stars$1.48-3.3%N/AN/A$260K$23.84M0.00100Gap DownCAPSCapstone TherapeuticsN/A$1.51-5.0%N/AN/A$251K$43.42M0.0038MYMDMyMD PharmaceuticalsN/A$0.10-6.3%N/A-94.7%$242KN/A0.006Gap DownHigh Trading VolumeVINCVincerx Pharma3.1812 of 5 stars$0.04-7.5%$40.00+92,923.3%-99.7%$225KN/A0.0060Gap UpUPCUniverse PharmaceuticalsN/A$3.72-2.9%N/A-99.9%$160K$19.29M0.00220 Related Companies and Tools Related Companies Hepion Pharmaceuticals Competitors Biophytis Competitors Virpax Pharmaceuticals Competitors Viracta Therapeutics Competitors NuCana Competitors Bon Natural Life Competitors Capstone Therapeutics Competitors MyMD Pharmaceuticals Competitors Vincerx Pharma Competitors Universe Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.